一种联合考虑比较效果研究与患者偏好的贝叶斯模型可能有助于为GRADE推荐提供信息:在类风湿关节炎治疗推荐中的应用
该研究采用贝叶斯方法联合考虑患者偏好与比较效果研究,以估计早期类风湿关节炎的首选治疗。利用离散选择实验测得的患者偏好对网络Meta分析的利益与危害结局及其他考虑因素进行加权。结果估计多数患者偏好三联疗法作为初始治疗(78%)或甲氨蝶呤应答不足后(62%),与现有指南形成对比,该法可能有助于为GRADE治疗推荐提供信息。
要点
- 多数患者偏好三联疗法作为初始治疗(78%)或甲氨蝶呤应答不足后(62%)。
- 甲氨蝶呤应答不足后选择更为分化,提示决策辅助工具可能有帮助。
- 该贝叶斯方法联合考虑患者偏好与比较效果,可能有助于为GRADE推荐提供信息。
核心结论
- 许多早期类风湿关节炎患者可能偏好三联疗法而非其他治疗方案,与现有指南形成对比。
- 该新方法可能有助于为GRADE治疗推荐提供信息。
研究设计与样本
- 采用贝叶斯分析,联合考虑患者偏好与比较效果研究,估计早期类风湿关节炎的首选治疗。
- 使用离散选择实验测得的患者偏好对网络Meta分析的利益与危害结局及其他考虑因素(给药、罕见不良事件)进行加权。
- 分析中考虑了患者偏好的变异性以及患者偏好和治疗效应的不精确性,这些均为GRADE方法中的关键考虑因素。
主要发现
- 估计大多数患者偏好三联疗法作为初始治疗(78%)。
- 估计大多数患者偏好三联疗法作为甲氨蝶呤应答不足后的治疗(62%)。
- 选择三联疗法作为初始治疗的概率更远离50%(无差异点)的患者更多,使预测更有把握,提示可作出更强的推荐。
- 甲氨蝶呤应答不足后选择更为分化,提示决策辅助工具可能有帮助。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: The objective of the study was to estimate the preferred treatment for early rheumatoid arthritis using a novel Bayesian approach that jointly considers patients' preferences and comparative effectiveness research. STUDY DESIGN AND SETTING: We estimated the preferred treatment using patients' preferences measured in a discrete-choice experiment to apply weights to benefit and harm outcomes from a network meta-analysis and other considerations (dosing, rare adverse events). Using Bayesian analyses, we considered the variability in patients' preferences and the imprecision in both patients' preferences and the treatment effects; all key considerations in the Grading of Recommendations Assessment, Development, and Evaluation approach. RESULTS: We estimated that most patients in our population would prefer triple therapy as initial treatment (78%) or after an inadequate response to methotrexate (62%). The probability of choosing triple therapy as initial treatment was further from 50% (the point of indifference) for more patients, making our prediction more confident, and suggesting a stronger recommendation could be made. After an inadequate response to methotrexate, the choice was more split, suggesting a decision aid may be helpful. CONCLUSION: Using a novel approach, we estimated that many patients with early rheumatoid arthritis may prefer triple therapy to other treatment options, in contrast to existing guidelines. This offers an approach that may help inform Grading of Recommendations Assessment, Development, and Evaluation treatment recommendations.
引用
- Hazlewood GS, Bombardier C, Tomlinson G, et al. A Bayesian model that jointly considers comparative effectiveness research and patients' preferences may help inform GRADE recommendations: an application to rheumatoid arthritis treatment recommendations. J Clin Epidemiol. 2017. PMID: 29051108. doi:10.1016/j.jclinepi.2017.10.003
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。